An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices

A Single Center Explorative Study of the Treamtent ofDiabetes Patients With Contact Dermatitits Caused byInsulin Infusion Pump or Glucose Monitor

A feasibility study of treatment with a occlusive medical device or patch in pediatric patients with type 1 diabetes suffering from irritative contact dermatitis due to diabetes devices.

Inclusion Criteria:

• Signed informed consent, and for patients under the legal age consent by a legal guardian
• Clinically confirmed, active and evaluable irritant contact dermatitis (ICD)
• Age 6-20 at the time of signing the informed consent form (ICF)
• Ability to answer study questionnaires

Exclusion Criteria:

• Any type of skin irritation other than ICD
• Use of occlusive therapy for the treatment of their ICD, or unwilling to refrain from this treatment for duration of study
• For any other reason considered unsuitable by the investigator
• Pregnant or of child-bearing potential unwilling to use acceptable effective contraception